A Case Series of Serious Adverse Events Following Anti-VEGF Intravitreal Injections

Andreea Alexandra Mihaela Muşat1,2, Nicoleta Zamfiroiu-Avidis2, Cornel Ştefan3

  • 1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

PubMed
Summary

Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy can cause serious adverse effects like endophthalmitis and cataract. Vigilance in patient selection and risk-benefit assessment is crucial for safe treatment of retinal diseases.